Global COPD Drugs Market Expected to Witness a Sustainable Growth over 2025- QY Research

This report studies the global COPD Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global COPD Drugs market by companies, region, type and end-use industry.

COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors, steroids, combination therapies, etc.

One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.

The bronchodilators segment is one of the fastest growing segments of the COPD drugs market. Bronchodilators help relax bronchial muscles resulting in normal breathing. These drugs can be categorized into three types, namely beta-sympathomimetic, anticholinergics, and xanthine derivatives.

In 2017, the global COPD Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global top players, covered

    Pfizer

    Novartis

    GlaxoSmithKline

    Merck

    Abbott Laboratories

    Boehringer Ingelheim

    AstraZeneca

    Roche Holding AG

    Teva Pharmaceutical Industries

    Vectura Group

    Mylan NV

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China


    Japan

    Southeast Asia

    India

Market segment by Type, the product can be split into

    Bronchodilators

    PDE-4 Inhibitors

    Steroids

    Combination Therapies

    Others

Market segment by Application, split into

    Hospitals

    Clinics

    Others

Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1732590.html

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com or tinaning@qyresearch.com

Web: www.qyresearchglobal.com

For other region, contact number given below

+86 108 294 5717 Beijing

+852 3062 8839 HK